Mattioli, R <br/><br/>
Long-survival in responding patients with metastatic breast cancer treated with doxorubicin-docetaxel combination. A multicentre phase II trial.  [electronic resource] 

 -  Anticancer research   
 - 3257-61 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>0250-7005 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Breast Neoplasms--drug therapy<br/>Disease-Free Survival<br/>Docetaxel<br/>Doxorubicin--administration & dosage<br/>Female<br/>Humans<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Survival Rate<br/>Taxoids--administration & dosage